SEC Form 3 · accession 0001104659-18-057860
Y-mAbs Therapeutics, Inc. · YMAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Biotech ApS WG
10% Owner
Period of report
Sep 20, 2018
Accepted (ET)
Sep 20, 2018 · 6:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001722964
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 5,010,000 | D |
Table II — derivative securities
No Table II lines on this filing.